DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vfend (Voriconazole) - Serious Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Events (585)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) serious events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 585   Next >>

Possible Vfend side effects in 78 year old male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: 78 year old male

Reactions: Aspergillosis, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in male

Reported by a physician from France on 2012-08-27

Patient: male

Reactions: Thrombotic Microangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    Indication: Product Used FOR Unknown Indication
    End date: 2012-03-06

Bactrim DS
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Delursan
    Administration route: Oral
    Indication: Cholestasis

Effexor
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Indication: Vitamin B12 Deficiency
    End date: 2012-04-05

Heparin Calcium
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Indication: Product Used FOR Unknown Indication

Nicardipine HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Indication: Immunosuppression

Tiorfan
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-25

Tranxene
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Indication: Prophylaxis

Zolpidem
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18



Possible Vfend side effects in male

Reported by a physician from France on 2012-08-27

Patient: male

Reactions: Multi-Organ Failure, Thrombotic Microangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    End date: 2012-03-06

Clorazepate Dipotassium
    Dosage: unknown dose daily
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Delursan
    Indication: Cholestasis

Effexor
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Indication: Vitamin B12 Deficiency
    End date: 2012-04-05

Heparin Calcium
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Indication: Hypothyroidism

Nicardipine HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Indication: Prophylaxis
    End date: 2012-05-11

Phenoxymethyl Penicillin
    Dosage: 2 m iu daily
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23

Solu-Medrol
    Indication: Immunosuppression

Sulfamethoxazole and Trimethoprim
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Tiorfan
    Administration route: Oral
    Indication: Prophylaxis Against Diarrhoea
    End date: 2012-04-25

Valganciclovir
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Indication: Prophylaxis

Zolpidem
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18

Other drugs received by patient: Vidaza; Cytarabine; Idarubicin HCL



Possible Vfend side effects in 59 year old male

Reported by a physician from United States on 2012-08-27

Patient: 59 year old male

Reactions: Drug Ineffective, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: 52 year old female

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24

Patient: male

Reactions: Confusional State, Graft Versus Host Disease, RED Blood Cell Schistocytes Present, Haptoglobin Abnormal, Thrombotic Microangiopathy, Hyperuricaemia, Graft Versus Host Disease in Liver, Multi-Organ Failure, Thrombocytopenic Purpura, Thrombocytopenia, Kussmaul Respiration, Haemolysis, Haematotoxicity, Epstein-Barr Virus Infection, Renal Failure, Renal Impairment, Cytomegalovirus Infection, Nervous System Disorder, Human Herpesvirus 6 Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    Dosage: 20 g, qd
    End date: 2012-03-06

Bactrim DS
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Delursan
    Dosage: 1.5 g, unk
    Administration route: Oral
    Indication: Cholestasis

Effexor
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Indication: Vitamin Supplementation
    End date: 2012-04-05

Heparin Calcium
    Dosage: 7500 (units unknown), once daily
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Dosage: 150 ug, qd
    Indication: Hypothyroidism

Nicardipine HCL
    Dosage: 50 mg, qd
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Dosage: 2 miu, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Indication: Immunosuppression

Tiorfan
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Prophylaxis Against Diarrhoea
    End date: 2012-04-25

Tranxene
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Dosage: 900 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Dosage: 400 ukn, qd
    Indication: Prophylaxis

Zolpidem
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18

Other drugs received by patient: Ganciclovir Sodium; Vidaza; Mycophenolate Mofetil (Cellcept)



Possible Vfend side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 57.0 kg (125.4 pounds)

Reactions: Bronchopulmonary Aspergillosis, Drug Interaction, Anaemia Macrocytic, Hypertriglyceridaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient possibly interacting with the suspect drug:
Lipitor
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-19
    End date: 2012-02-15

Other drugs received by patient: Neoral; Basen; Sulfamethoxazole and Trimethoprim; Prednisolone; Bonalen(alendronate Sodium); Fungizone; Lansoprazole; Candesartan Cilexetil; Metformin HCL



Possible Vfend side effects in 65 year old female

Reported by a physician from Switzerland on 2012-08-24

Patient: 65 year old female, weighing 38.0 kg (83.6 pounds)

Reactions: Hyperkalaemia, Adrenal Insufficiency, Hyponatraemia, Convulsion

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-31

Prednisone
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Start date: 2012-07-27

Prednisone
    Dosage: 30 mg, 1x/day
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Prednisone
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-17

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-07-26

Other drugs received by patient: Prograf; Zithromax; Aspirin; Prograf; Myfortic; Liquaemin INJ



Possible Vfend side effects in 78 year old male

Reported by a pharmacist from Japan on 2012-08-24

Patient: 78 year old male

Reactions: Disorientation, Delirium, Eye Disorder

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 68 year old male

Reported by a physician from United States on 2012-08-24

Patient: 68 year old male

Reactions: Hepatic Enzyme Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in

Reported by a physician from Poland on 2012-08-21

Patient:

Reactions: Dizziness, Altered State of Consciousness

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 51 year old female

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: 51 year old female, weighing 47.6 kg (104.8 pounds)

Reactions: Pneumonia, International Normalised Ratio Increased, Blood Disorder, Drug Interaction, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient possibly interacting with the suspect drug:
Coumadin
    Dosage: 2.5 mg, 1x/day one and half tablet
    Administration route: Oral
    Indication: Anticoagulant Therapy
    Start date: 2012-02-01



Possible Vfend side effects in male

Reported by a physician from France on 2012-08-17

Patient: male

Reactions: Thrombotic Microangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    Indication: Product Used FOR Unknown Indication
    End date: 2012-03-06

Bactrim DS
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Delursan
    Administration route: Oral
    Indication: Cholestasis

Effexor
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Indication: Vitamin B12 Deficiency
    End date: 2012-04-05

Heparin Calcium
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Indication: Product Used FOR Unknown Indication

Nicardipine HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Indication: Immunosuppression

Tiorfan
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-25

Tranxene
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Indication: Prophylaxis

Zolpidem
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18



Possible Vfend side effects in 59 year old male

Reported by a physician from United States on 2012-08-17

Patient: 59 year old male

Reactions: Leukaemia, Renal Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 82 year old male

Reported by a physician from Japan on 2012-08-17

Patient: 82 year old male, weighing 50.3 kg (110.7 pounds)

Reactions: Photosensitivity Reaction, Squamous Cell Carcinoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Tamsulosin HCL
    Dosage: 0.2 mg, 1x/day
    Start date: 2006-11-08
    End date: 2007-03-08

Vfend
    Dosage: 200 mg, 3x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2006-08-30
    End date: 2011-11-07

Vfend
    Dosage: unk
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-11-01

Other drugs received by patient: Amlodipine; Trichlormethiazide; Ludiomil; Atarax; Amitriptyline HCL; Ferrous Fumarate; Clarithromycin; Blostar M



Possible Vfend side effects in 31 year old female

Reported by a physician from Nigeria on 2012-08-14

Patient: 31 year old female

Reactions: Fungal Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Itraconazole; Meropenem; Fluconazole



Possible Vfend side effects in 66 year old male

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient: 66 year old male, weighing 63.5 kg (139.7 pounds)

Reactions: Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 56 year old female

Reported by a physician from United States on 2012-08-14

Patient: 56 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 66 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13

Patient: 66 year old male

Reactions: Thrombotic Microangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin
    Dosage: form: solution
    End date: 2012-03-06

Bactrim DS
    Administration route: Oral
    End date: 2012-03-22

Delursan
    Administration route: Oral
    Indication: Cholestasis
    End date: 2012-05-11

Effexor
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Administration route: Oral
    Indication: Vitamin B12 Deficiency
    End date: 2012-04-05

Heparin
    End date: 2012-03-21

Levothyroxine Sodium
    Administration route: Oral
    Indication: Hypothyroidism
    End date: 2012-05-11

Nicardipine HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Administration route: Oral
    End date: 2012-05-11

Phenoxymethyl Penicillin
    Dosage: 2 millions iu daily
    End date: 2012-03-22

Plitican
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Indication: Immunosuppression
    End date: 2012-05-11

Tiorfan
    Administration route: Oral
    End date: 2012-04-25

Tranxene
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Administration route: Oral
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Dosage: powder for solution for perfusion
    End date: 2012-05-11

Zolpidem Tartrate
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18



Possible Vfend side effects in 66 year old male

Reported by a physician from France on 2012-08-10

Patient: 66 year old male

Reactions: Multi-Organ Failure, Thrombotic Microangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    End date: 2012-03-06

Clorazepate Dipotassium
    Dosage: unknown dose daily
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Effexor
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Indication: Vitamin B12 Deficiency
    End date: 2012-04-05

Heparin Calcium
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Indication: Hypothyroidism

Nicardipine HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Dosage: 2 m iu daily
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23

Solu-Medrol
    Indication: Immunosuppression

Sulfamethoxazole and Trimethoprim
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Tiorfan
    Administration route: Oral
    Indication: Prophylaxis Against Diarrhoea
    End date: 2012-04-25

Ursodiol
    Administration route: Oral
    Indication: Cholestasis

Valganciclovir
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Indication: Prophylaxis

Zolpidem Tartrate
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18

Other drugs received by patient: Idarubicin HCL; Vidaza; Cytarabine



Possible Vfend side effects in 31 year old female

Reported by a physician from Nigeria on 2012-08-10

Patient: 31 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 74 year old female

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: 74 year old female, weighing 53.5 kg (117.7 pounds)

Reactions: Renal Failure, Organ Failure, Full Blood Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Morphine



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-10

Patient: male

Reactions: Confusional State, Graft Versus Host Disease, RED Blood Cell Schistocytes Present, Haptoglobin Abnormal, Thrombotic Microangiopathy, Hyperuricaemia, Multi-Organ Failure, Thrombocytopenic Purpura, Thrombocytopenia, Kussmaul Respiration, Haematotoxicity, Haemolysis, Renal Impairment, Renal Failure, Cytomegalovirus Infection, Nervous System Disorder, Human Herpesvirus 6 Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    Dosage: 20 g, qd
    End date: 2012-03-06

Bactrim DS
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Delursan
    Dosage: 1.5 g, unk
    Administration route: Oral
    Indication: Cholestasis

Effexor
    Dosage: unk
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Dosage: unk
    Indication: Vitamin Supplementation
    End date: 2012-04-05

Heparin Calcium
    Dosage: 7500 (units unknown), once daily
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Dosage: 150 ug, qd
    Indication: Hypothyroidism

Nicardipine HCL
    Dosage: 50 mg, qd
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Dosage: unk
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Dosage: 2 miu, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Dosage: unk
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Dosage: unk
    Indication: Immunosuppression

Tiorfan
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Prophylaxis Against Diarrhoea
    End date: 2012-04-25

Tranxene
    Dosage: unk
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Dosage: 900 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Dosage: 400 unk, qd
    Indication: Prophylaxis

Zolpidem Tartrate
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18

Other drugs received by patient: Ganciclovir Sodium; Cellcept; Vidaza



Possible Vfend side effects in 82 year old male

Reported by a physician from Japan on 2012-08-10

Patient: 82 year old male, weighing 50.3 kg (110.7 pounds)

Reactions: Photosensitivity Reaction, Squamous Cell Carcinoma

Drug(s) suspected as cause:
Vfend
    Dosage: unk
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-11-01

Vfend
    Dosage: 200 mg, 3x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2006-08-30
    End date: 2011-11-07

Other drugs received by patient: Trichlormethiazide; Tamsulosin HCL; Ferrous Fumarate; Ludiomil; Clarithromycin; Blostar M; Atarax; Amitriptyline HCL; Amlodipine



Possible Vfend side effects in 66 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-10

Patient: 66 year old male

Reactions: Thrombotic Microangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    Dosage: 20 g daily
    End date: 2012-03-06

Bactrim DS
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Delursan
    Dosage: 1.5 g daily
    Administration route: Oral
    Indication: Cholestasis

Effexor XR
    Dosage: variable dose
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Dosage: 5 (unspecified unit) daily
    Indication: Vitamin B12 Deficiency
    End date: 2012-04-05

Heparin Calcium
    Dosage: 7500 (unspecified unit) daily
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Dosage: 150 ug daily
    Indication: Hypothyroidism

Nicardipine HCL
    Dosage: 1 df daily
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Dosage: variable dose
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Dosage: 2 miu daily
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Dosage: variable dose
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Dosage: variable dose
    Indication: Prophylaxis
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Dosage: variable dose
    Indication: Immunosuppression

Tiorfan
    Dosage: 600 mg daily
    Administration route: Oral
    Indication: Diarrhoea
    End date: 2012-04-25

Tranxene
    Dosage: variable dose
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Dosage: 900 mg daily
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Dosage: 400 (unspecified unit) daily
    Indication: Prophylaxis

Zolpidem Tartrate
    Dosage: 1 dosage form (df) daily
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18



Possible Vfend side effects in 84 year old female

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: 84 year old female, weighing 72.6 kg (159.6 pounds)

Reactions: Eye Naevus, Blood Potassium Abnormal, Eye Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: Haemorrhage Subcutaneous

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 74 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09

Patient: 74 year old female

Reactions: Myocardial Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 64 year old female

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: 64 year old female

Reactions: Impaired Driving Ability, Anxiety, Renal Failure, Sleep Disorder, Dental Caries, Vision Blurred, Depression, Blindness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 62 year old male

Reported by a pharmacist from United States on 2012-08-08

Patient: 62 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Renal Artery Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend
    Dosage: 250 mg, 2x/day
    Administration route: Oral
    Indication: Aspergillosis
    Start date: 2009-01-01

Vfend



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014